| 臺大學術典藏 |
2021-10-26T02:34:55Z |
Psychobehavioral response and weight loss prediction in a hospital-Based weight reduction program
|
Tseng M.-C.; Lee Y.-J.; Chen S.-Y.; MING-BEEN LEE; Lin K.-H.; Chen P.-R.; Lai J.-S. |
| 臺大學術典藏 |
2021-10-26T02:34:54Z |
Hyperleptinemia in Subjects with Persistent Partial Posttraumatic Stress Disorder after a Major Earthquake
|
Liao S.-C.; MING-BEEN LEE; Lee Y.-J.; Huang T.-S. |
| 臺大學術典藏 |
2021-10-26T02:34:54Z |
Development and verification of validity and reliability of a short screening instrument to identify psychiatric morbidity
|
MING-BEEN LEE; Liao S.-C.; Lee Y.-J.; Wu C.-H.; Tseng M.-C.; Gau S.-F.; Rau C.-L. |
| 臺大學術典藏 |
2021-10-26T02:34:54Z |
Brain tumor presenting as anorexia nervosa in a 19-year-old man
|
Lin L.; Liao S.-C.; Lee Y.-J.; Tseng M.-C.; MING-BEEN LEE |
| 臺大學術典藏 |
2021-10-26T02:34:53Z |
Response of Taiwanese obese binge eaters to a hospital-based weight reduction program
|
Tseng M.-C.; MING-BEEN LEE; Chen S.-Y.; Lee Y.-J.; Lin K.-H.; Chen P.-R.; Lai J.-S. |
| 臺大學術典藏 |
2021-10-26T02:34:53Z |
Long-term outcome of bulimia nervosa in Taiwanese
|
Tseng M.-C.; MING-BEEN LEE; Lee Y.-J.; Chen Y.-Y. |
| 臺大學術典藏 |
2021-10-26T02:34:52Z |
Validity of the five-item Brief Symptom Rating Scale among subjects admitted for general health screening
|
Chen H.-C.; Wu C.-H.; Lee Y.-J.; Liao S.-C.; MING-BEEN LEE |
| 臺大學術典藏 |
2021-10-26T02:34:52Z |
Intermediate-term outcome of psychiatric inpatients with major depression
|
Tseng M.-C.; Cheng I.-C.; Lee Y.-J.; MING-BEEN LEE |
| 臺大學術典藏 |
2021-10-26T02:34:52Z |
Outcome of short-term hospitalization in a psychosomatic ward
|
Huang L.-C.; Liao S.-C.; Lee Y.-J.; Tseng M.-C.; Wu C.-H.; MING-BEEN LEE |
| 臺大學術典藏 |
2021-10-26T02:34:51Z |
The counterbalance between leptin and cortisol may be associated with comorbid depression and anxiety [4]
|
Liao S.-C.; MING-BEEN LEE; Lee Y.-J.; Huang T.-S. |
| 臺大學術典藏 |
2021-10-14T02:45:56Z |
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|
Chen C.-H.; Dickman K.G.; CHAO-YUAN HUANG; Moriya M.; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; Lee Y.-J.; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:45:53Z |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.; Hsu J.-S.; CHAO-YUAN HUANG; Wang S.-M.; Lee Y.-J.; Huang K.-H.; Yu H.-J.; Pu Y.-S.; Liang P.-C. |
| 臺大學術典藏 |
2021-10-14T02:45:48Z |
Paragangliomas of the urinary bladder: A report of 6 cases and review of the literature
|
Chang Y.-K.; Chiang I.-N.; Chen C.-H.; Wang S.-M.; Lee Y.-J.; Pu Y.-S.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:45:47Z |
Malignant ureteral obstruction: Functional duration of metallic versus polymeric ureteral stents
|
Chow P.-M.; Chiang I.-N.; Chen C.-Y.; Huang K.-H.; Hsu J.-S.; Wang S.-M.; Lee Y.-J.; Yu H.-J.; Pu Y.-S.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:45:44Z |
Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
|
Chen C.-H.; Dickman K.G.; CHAO-YUAN HUANG; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; Lee Y.-J.; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:45:27Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Hung S.-C.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:45:22Z |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Cheng Y.-T.; CHAO-YUAN HUANG; Chen C.-H.; Chiu S.-T.; Hong J.-H.; Pu Y.-S.; Liu S.-P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Chiang I.-N.; Hung S.-C.; Chiang C.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:39Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S. |
| 臺大學術典藏 |
2021-09-04T06:11:24Z |
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan
|
Bennett H.; Waser N.; Johnston K.; JIA-HORNG KAO; Lim Y.-S.; Duan Z.-P.; Lee Y.-J.; Wei L.; Chen C.-J.; Sievert W.; Yuan Y.; Li H. |
| 臺大學術典藏 |
2021-09-04T06:11:15Z |
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis
|
JIA-HORNG KAO; Jensen D.M.; Manns M.P.; Jacobson I.; Kumada H.; Toyota J.; Heo J.; Yoffe B.; Sievert W.; Bessone F.; Peng C.-Y.; Roberts S.K.; Lee Y.-J.; Bhore R.; Mendez P.; Hughes E.; Noviello S. |
| 臺大學術典藏 |
2021-09-04T06:11:11Z |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
|
JIA-HORNG KAO; Lee Y.-J.; Heo J.; Ahn S.-H.; Lim Y.-S.; Peng C.-Y.; Chang T.-T.; Torbeyns A.; Hughes E.; Bhore R.; Noviello S. |
| 臺大學術典藏 |
2021-09-04T05:17:13Z |
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
|
JIA-HORNG KAO; Yu M.-L.; Peng C.-Y.; Heo J.; Chu C.-J.; Chang T.-T.; Lee Y.-J.; Hu T.-H.; Yoon K.T.; Paik S.W.; Lim Y.S.; Ahn S.H.; Isakov V.; McPhee F.; Hu W.; Scott Swenson E.; Yin P.D.; Treitel M. |
| 臺大學術典藏 |
2021-09-02T00:04:07Z |
Modulation of QCSE in InGaN-based LEDs with truncated-hexagonal-pyramid patterned-sapphire substrates
|
Chien C.-Y;Chen M.-H;Pai C.-W;Lee Y.-J;Huang C.-C;Su V.-C;Kuan C.-H.; Chien C.-Y; Chen M.-H; Pai C.-W; Lee Y.-J; Huang C.-C; Su V.-C; Kuan C.-H.; CHIEH-HSIUNG KUAN |
| 臺大學術典藏 |
2021-09-02T00:03:29Z |
Convolutional neural networks predict mitochondrial structures from label-free microscopy images
|
Hsu C.-M;Lee Y.-J;Wei A.-C.; Hsu C.-M; Lee Y.-J; Wei A.-C.; AN-CHI WEI |
| 臺大學術典藏 |
2021-08-31T06:29:32Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo M.; ANN-LII CHENG; Park J.-W.; Park J.H.; Liang P.-C.; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y. |
